Patrick Daly

Articles by Patrick Daly

Patrick DalySickle Cell Disease | September 21, 2023
Research showed the historical effect of pneumococcal conjugate vaccines on infections in children with sickle cell disease.
Read More
Patrick DalyColorectal Cancer | September 20, 2023
Maintenance with cetuximab monotherapy appeared to improve PFS and OS in patients with metastatic colorectal cancer.
Patrick DalyLung Cancer | September 19, 2023
Early menopause, shortened reproductive span, and other reproductive factors were linked to risk of lung cancer in women.
Patrick DalySOHO 2023 | September 14, 2023
Patients with ibrutinib dose reduction after an AE had longer treatment length and similar efficacy versus no dose reduction.
Patrick DalySOHO 2023 | September 14, 2023
A study on patterns in patients with CLL found the RFC regimen appeared to be most effective for OS and response rates.
Patrick DalySOHO 2023 | September 14, 2023
Patients with chronic lymphocytic leukemia experience more anxiety when receiving intravenous versus oral treatments.
Patrick DalySOHO 2023 | September 14, 2023
Patients with CLL who relapsed after HSCT and then received venetoclax therapy achieved outcomes consistent with trial data.
Patrick DalyFuture of Medicine | September 8, 2023
Dr. Annie Evans, senior director of research and development at Metabolon, Inc., about the science of metabolomics.
Patrick DalyGEP-NETs | September 1, 2023
A study found key tumor heterogeneities, including Ki-67 indices, might contribute to disease progression in GEP-NETs.
Patrick DalyGEP-NETs | August 25, 2023
Lu-177-dotatate in PRRT appeared to treat GEP-NETs, though prior internal radiation may impede responses or worsen survival.
Patrick DalyADHD | August 22, 2023
Symptom burden, gender, and social functioning were factors that increased suicidal spectrum behaviors in patients with ADHD.
Patrick DalyNon-Small Cell Lung Cancer | August 21, 2023
JK5G postbiotics may improve gut microbiota, QOL, and appetite in patients with advanced NSCLC on PD-1 inhibitor therapy.
Patrick DalySleep Disorders | August 9, 2023
Excessive daytime sleepiness was linked to a higher risk of premature all-cause death in female patients with OSA.
Patrick DalySleep Disorders | August 9, 2023
Survey data showed patients with idiopathic hypersomnia self-reported substantially impaired QoL and daily functioning.
Patrick DalySleep Disorders | August 9, 2023
Researchers developed a faster calculation for hypoxic burden using desaturations that was comparable with manual scoring.
Patrick DalySleep Disorders | August 9, 2023
CPAP did not yield a cardiovascular benefit in patients with CAD and OSA, regardless of excessive daytime sleepiness status.
Patrick DalyHemophilia | August 1, 2023
Poor bleeding rates seen despite flawed data across studies on congenital hemophilia A without inhibitors on FVIII treatment.
Patrick DalyHeart Failure | July 28, 2023
Sacubitril/valsartan therapy improved outcomes compared with enalapril in heart failure with preserved ejection fraction.
Patrick DalyRheumatoid Arthritis | July 26, 2023
Abatacept improved outcomes for rheumatoid arthritis refractory to methotrexate or TNFi versus rituximab or tocilizumab.
Patrick DalyDiabetes | July 25, 2023
Elevated IGFs predicted poor outcomes in type 2 diabetes, and levels remained high after 3 years of canagliflozin treatment.